{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:38:11Z","timestamp":1740155891290,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/nrrheum.2015.111","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T06:20:14Z","timestamp":1439274014000},"page":"569-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Optimized treatment algorithms for digital vasculopathy in SSc"],"prefix":"10.1038","volume":"11","author":[{"given":"Maurizio","family":"Cutolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Sulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"BFnrrheum2015111_CR1","doi-asserted-by":"publisher","unstructured":"Hughes, M.  et al. Consensus best practice pathway of the UK Systemic Sclerosis Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford) \n                    http:\/\/dx.doi.org\/10.1093\/rheumatology\/kev201\n                    \n                  .","DOI":"10.1093\/rheumatology\/kev201"},{"key":"BFnrrheum2015111_CR2","doi-asserted-by":"publisher","first-page":"e006389","DOI":"10.1136\/bmjopen-2014-006389","volume":"5","author":"R Garner","year":"2015","unstructured":"Garner, R., Kumari, R., Lanyon, P., Doherty, M. & Zhang, W. Epidemiology prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies. BMJ Open 5, e006389 (2015).","journal-title":"BMJ Open"},{"key":"BFnrrheum2015111_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/CLEP.S75482","volume":"7","author":"PJ Nietert","year":"2015","unstructured":"Nietert, P. J.  et al. Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort. Clin. Epidemiol. 7, 161\u2013168 (2015).","journal-title":"Clin. Epidemiol."},{"key":"BFnrrheum2015111_CR4","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1002\/art.22636","volume":"56","author":"M Cutolo","year":"2007","unstructured":"Cutolo, M., Pizzorni, C. & Sulli, A. Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy : comment on the article by Hirschl  et al. Arthritis Rheum. 56, 2102\u20132103 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2015111_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2010.104","volume":"6","author":"M Cutolo","year":"2010","unstructured":"Cutolo, M., Sulli, A. & Smith, V. Assessing microvascular changes in systemic sclerosis diagnosis and management. Nat. Rev. Rheumatol. 6, 578\u2013587 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2015111_CR6","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3899\/jrheum.130528","volume":"40","author":"V Smith","year":"2013","unstructured":"Smith, V.  et al. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J. Rheumatol. 40, 2023\u20132028 (2013).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2015111_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00393-013-1157-2","volume":"72","author":"M Cutolo","year":"2013","unstructured":"Cutolo, M. Disease modification in systemic sclerosis. Do integrated approaches offer new challenges? Z. Rheumatol. 72, 326\u2013328 (2013).","journal-title":"Z. Rheumatol."},{"issue":"2 Suppl. 81","key":"BFnrrheum2015111_CR8","first-page":"165","volume":"32","author":"J Avouac","year":"2014","unstructured":"Avouac, J. & Allanore, Y. Targeted immunotherapies in systemic sclerosis. Clin. Exp. Rheumatol. 32 (2 Suppl. 81), 165\u2013172 (2014).","journal-title":"Clin. Exp. Rheumatol."},{"key":"BFnrrheum2015111_CR9","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/art.20676","volume":"50","author":"JH Korn","year":"2004","unstructured":"Korn, J. H.  et al. Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum. 50, 3985\u20133993 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2015111_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3899\/jrheum.131284","volume":"41","author":"M Cutolo","year":"2014","unstructured":"Cutolo, M.  et al. Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. J. Rheumatol. 41, 881\u2013886 (2014).","journal-title":"J. Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.111","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2015.111.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:36:36Z","timestamp":1684470996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2015.111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFnrrheum2015111"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2015.111","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"type":"print","value":"1759-4790"},{"type":"electronic","value":"1759-4804"}],"subject":[],"published":{"date-parts":[[2015,8,11]]},"assertion":[{"value":"11 August 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}